Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in Sweden
Kiadaliri AA, Gerdtham UG, Eliasson B and Steen Carlsson K
Diabetes Therapy 2014; 5(4): 591-607
DOI: 10.1007/s13300-014-0080-0
